Singapore Clinical Trial: A double-blind, randomized, placebo controlled pilot trial to assess the efficacy of L. reuteri in patients with Functional dyspepsia

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A double-blind, randomized, placebo controlled pilot trial to assess the efficacy of L. reuteri in p... Read More

Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY4064912 in Healthy Participants and Participants with Overweight or Obesity.

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to Ev... Read More

Singapore Clinical Trial: Topical Therapy for Closure of Small to Medium-Sized Macular Hole

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'Topical Therapy for Closure of Small to Medium-Sized Macular Hole'. The following are the other rele... Read More

Singapore Clinical Trial: A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the effects of oral TRPC6 inhibitor BI 764198 taken over a 104 week treatment period in adult and adolescent participants with primary focal segmental glomerulosclerosis (pFSGS) or genetic FSGS related to TRPC6 gene variants

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the effe... Read More

Singapore Clinical Trial: A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate ... Read More

Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4167586 in Participants with Obesity or Overweight who are Otherwise Healthy.

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate the... Read More

Singapore Clinical Trial: A Phase 1/2, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Assess the Safety, Pharmacokinetics, and Efficacy of AMG 732 in Healthy Subjects and Subjects with Moderate-to-Severe Active Thyroid Eye Disease

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Assess the Safety, ... Read More

Singapore Clinical Trial: Immunogenicity of Recombinant Zoster Vaccine in Long-term Solid Organ Transplant Recipients

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'Immunogenicity of Recombinant Zoster Vaccine in Long-term Solid Organ Transplant Recipients'. The fo... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of... Read More

Singapore Clinical Trial: Phase 3 Study of the Efficacy and Safety of ION582 in Children and Adults with Angelman Syndrome

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'Phase 3 Study of the Efficacy and Safety of ION582 in Children and Adults with Angelman Syndrome'. T... Read More

• ««
• «
• 1299
• 1300
• 1301
• 1302
• 1303
• 1304
• 1305
• 1306
• 1307
• 1308
• »
• »»